COMPARATIVE ANALYSIS OF QUANTITATIVE COMPUTED TOMOGRAPHY DATA AND HISTOLOGICAL FINDINGS IN PATIENTS WITH GIANT CELL BONE TUMOR TREATED WITH DENOSUMAB

Background. Giant cell tumor of bone (GCTB) is a common benign lesion accounting for 4–9.5 % of all primary bone tumors. Although surgery is considered the method of choice in the treatment of GCT, however, denosumab, a genetically engineered drug with a novel mechanism of  action, has been recently...

ver descrição completa

Detalhes bibliográficos
Principais autores: S. A. Tabakaev, I. G. Frolova, I. I. Anisenya, N. V. Vasilyev, A. V. Bogoutdinova, P. K. Sitnikov
Formato: Artigo
Idioma:Russian
Publicado em: Russian Academy of Sciences, Tomsk National Research Medical Center 2021-05-01
coleção:Сибирский онкологический журнал
Assuntos:
Acesso em linha:https://www.siboncoj.ru/jour/article/view/1751

Registros relacionados